Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
Public ClinicalTrials.gov record NCT05266586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Placebo-Controlled, Double-Blind, Randomized, Phase 2 Study to Evaluate the Effect of Obicetrapib 10 mg Daily in Combination With Ezetimibe 10 mg Daily as an Adjunct to High-Intensity Statin Therapy: The ROSE 2 Study
Study identification
- NCT ID
- NCT05266586
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NewAmsterdam Pharma
- Industry
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Interventions
- Obicetrapib Drug
- Ezetimibe 10mg Drug
- Obicetrapib placebo Other
- Ezetimibe placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 8, 2022
- Primary completion
- Aug 11, 2022
- Completion
- Sep 7, 2022
- Last update posted
- Jul 2, 2024
2022
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velocity Clinical Research - Westlake d.b.a National Research Institute | Los Angeles | California | 90057 | — |
| Valley Clinical Trials, Inc. | Northridge | California | 91325 | — |
| Ocala Cardiovascular Research | Ocala | Florida | 34471 | — |
| A & R Research Group, LLC | Pembroke Pines | Florida | 33024 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Meridian Clinical Research - Savannah, GA | Savannah | Georgia | 31406 | — |
| Velocity Clinical Research | Meridian | Idaho | 83642 | — |
| Biofortis, Inc | Addison | Illinois | 60101 | — |
| Northwest Heart Clinical Research, LLC | Arlington Heights | Illinois | 60005 | — |
| Midwest Institute for Clinical Research | Indianapolis | Indiana | 46260 | — |
| Research Integrity LLC | Owensboro | Kentucky | 42303 | — |
| Oakland Medical Research Center | Troy | Michigan | 48085 | — |
| Mercury Street Medical | Butte | Montana | 59701 | — |
| Meridian Clinical Research- Springdale, OH | Cincinnati | Ohio | 45219 | — |
| Aventiv Research, Inc. | Columbus | Ohio | 43213 | — |
| Summit Research Group, LLC | Munroe Falls | Ohio | 44240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05266586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05266586 live on ClinicalTrials.gov.